HighTower Advisors LLC Purchases 8,000 Shares of KORU Medical Systems, Inc. $KRMD

HighTower Advisors LLC increased its holdings in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 18.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 51,400 shares of the company’s stock after purchasing an additional 8,000 shares during the period. HighTower Advisors LLC owned approximately 0.11% of KORU Medical Systems worth $131,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in KRMD. Vivaldi Capital Management LP acquired a new stake in KORU Medical Systems in the fourth quarter valued at approximately $82,000. Balyasny Asset Management L.P. purchased a new position in shares of KORU Medical Systems during the fourth quarter valued at approximately $84,000. Raymond James Financial Inc. purchased a new position in shares of KORU Medical Systems during the fourth quarter valued at approximately $118,000. Point72 Asia Singapore Pte. Ltd. boosted its position in shares of KORU Medical Systems by 145.6% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 31,818 shares of the company’s stock valued at $122,000 after buying an additional 18,863 shares during the last quarter. Finally, Jefferies Financial Group Inc. purchased a new position in shares of KORU Medical Systems during the fourth quarter valued at approximately $132,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Stock Performance

Shares of KORU Medical Systems stock opened at $4.06 on Friday. The business’s fifty day simple moving average is $3.77 and its 200 day simple moving average is $3.20. The firm has a market capitalization of $187.73 million, a P/E ratio of -45.11 and a beta of 0.57. KORU Medical Systems, Inc. has a 12 month low of $1.86 and a 12 month high of $5.05. The company has a current ratio of 2.91, a quick ratio of 2.25 and a debt-to-equity ratio of 0.01.

KORU Medical Systems (NASDAQ:KRMD) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.04. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%.The business had revenue of $10.20 million for the quarter, compared to analyst estimates of $9.46 million. As a group, analysts anticipate that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.